NCT02102230

Brief Summary

The purpose of this study is to investigate the efficacy of a group-based behavioral sleep intervention, and the incremental benefit provided by an adjunct sleep mobile app, on cannabis and sleep outcomes among cannabis dependent Veterans.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
111

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2014

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 2, 2014

Completed
7 months until next milestone

Study Start

First participant enrolled

November 3, 2014

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 24, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 24, 2017

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

August 28, 2019

Completed
Last Updated

August 28, 2019

Status Verified

July 1, 2019

Enrollment Period

2.4 years

First QC Date

March 25, 2014

Results QC Date

March 19, 2019

Last Update Submit

July 19, 2019

Conditions

Keywords

Sleep Initiation and Maintenance Disordersmarijuana abuseVeterans

Outcome Measures

Primary Outcomes (4)

  • Change in Cannabis Use Frequency Over Time

    Measures will include the Timeline Followback for cannabis. All of these measures are standard 7-day point prevalence estimates. In other words, the baseline measure is the number of uses in the 7 days prior to the baseline assessment day. The 6-weeks post-baseline is the number of uses in the 7 days prior to the 6-weeks post-baseline day, and so on.

    baseline, 6-weeks post-baseline, 2-weeks post-quit, 4 weeks post-quit, 6-months post-quit

  • Point Prevalence Abstinence Over the Three Post-quit Attempt Assessments

    point prevalence abstinence will be assessed using the Timeline Follow-back measure for cannabis count of number abstinent

    2-weeks post-quit, 4 weeks post-quit, 6-months post-quit

  • Change in Self-reported Sleep Quality Over Time

    Self-reported sleep quality will be measured using the Consensus Sleep Diary

    2-weeks post-quit, 4-weeks post-quit, 6-months post-quit

  • Change in Objective Sleep Quality Over Time

    Objective sleep quality will be measured via actigraphy

    2-weeks post-quit, 4-weeks post-quit, 6-months post-quit

Study Arms (3)

CBT-I

EXPERIMENTAL

Group Cognitive-Behavioral Therapy for Insomnia (CBT-I)

Behavioral: Cognitive Behavioral Therapy for Insomnia (CBT-I)

CBT-I-MA

ACTIVE COMPARATOR

Group Cognitive-Behavioral Therapy for Insomnia Plus Mobile App (CBT-I-MA)

Behavioral: Cognitive Behavioral Therapy for Insomnia Plus Mobile App (CBT-I-MA)

PC

PLACEBO COMPARATOR

Desensitization Treatment for Insomnia (DTI)

Behavioral: Desensitization Treatment for Insomnia

Interventions

This is a group-delivered version of the six-session Cognitive-Behavioral Treatment for Insomnia that has been disseminated throughout the VA. It incorporates psychoeducation, diary-based sleep assessment, estimation of sleep scheduling and efficiency, evaluation/mitigation of dysfunctional sleep-related beliefs/ behaviors, generation of sleep prescription (typically restriction), iterative review of sleep efficiency and prescription, and planning for maintenance of gains.

Also known as: CBT-I
CBT-I

This is a mobile-app-augmented, group-delivered version of the six-session Cognitive-Behavioral Treatment for Insomnia that has been disseminated throughout the VA. It incorporates psychoeducation, diary-based sleep assessment, estimation of sleep scheduling and efficiency, evaluation/mitigation of dysfunctional sleep-related beliefs/ behaviors, generation of sleep prescription (typically restriction), iterative review of sleep efficiency and prescription, and planning for maintenance of gains. The mobile-app augmentation substitutes a smartphone-based sleep diary with time-stamping of records to mitigate the common postponement of diary recording and consequent loss of validity. The app also records the sleep prescription, making it, along with links to web-based psychoeducational materials, easily accessible to users. The app also provides plots of bed times, wake times, and sleep efficiency over time, with the goal of promoting adherence.

Also known as: CBT-I-MA
CBT-I-MA

This is a group-delivered version of the sham sleep improvement treatment developed by Edinger which purports to "desensitize" the patient to the various aspects of the sleep experience which are presented as distressing.

Also known as: DTI
PC

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be included in the current study individuals must
  • be a Veteran 18 years or older
  • meet Diagnostic and Statistical Manual of Mental Disorders-5 diagnostic criteria for cannabis use disorder;
  • meet Diagnostic and Statistical Manual of Mental Disorders diagnostic criteria for insomnia;

You may not qualify if:

  • Individuals will be excluded based on evidence of the following:
  • inability to provide fully-informed written consent to participate;
  • history of, or current, psychotic symptoms;
  • current pregnancy;
  • Sleep apnea (\>5 on the STOP-Bang assessment);
  • active suicidal/homicidal intent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Palo Alto Health Care System, Palo Alto, CA

Palo Alto, California, 94304-1290, United States

Location

MeSH Terms

Conditions

Marijuana AbuseSleep Initiation and Maintenance Disorders

Interventions

Cognitive Behavioral TherapyDesensitization, Immunologic

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesImmunosuppression TherapyImmunotherapyImmunomodulationBiological TherapyTherapeuticsImmunologic TechniquesInvestigative Techniques

Results Point of Contact

Title
Kimberly Babson, PhD
Organization
VA Palo Alto Health Care System

Study Officials

  • Kimberly A Babson, PhD MA BS

    VA Palo Alto Health Care System, Palo Alto, CA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2014

First Posted

April 2, 2014

Study Start

November 3, 2014

Primary Completion

March 24, 2017

Study Completion

March 24, 2017

Last Updated

August 28, 2019

Results First Posted

August 28, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations